本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

20.83
-0.8100-3.74%
成交量:90.20万
成交额:1,896.95万
市值:26.63亿
市盈率:120.82
高:21.30
开:21.30
低:20.79
收:21.64
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:0.38
换手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
净资产收益率:7.48%
总资产收益率:3.53%
市净率:7.19
市盈率(LYR):120.82

数据加载中...

2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/22

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities